Biotime Inc (BTX) SEC Filing 8-K Material Event for the period ending Friday, March 8, 2019

Biotime Inc

CIK: 876343 Ticker: BTX

View differences made from one to another to evaluate Biotime Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biotime Inc.


Assess how Biotime Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biotime Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: BTX
CIK: 876343
Form Type: 8-K Corporate News
Accession Number: 0001493152-19-003026
Submitted to the SEC: Fri Mar 08 2019 4:05:10 PM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Friday, March 8, 2019
Industry: Biological Products No Disgnostic Substances
  1. Change in Assets
  2. Event for Officers
  3. Financial Exhibit
  4. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: